United States

India and the United States have intensified trade negotiations aimed at strengthening bilateral economic cooperation while ensuring that domestic priorities — particularly the protection of farmers and micro, small, and medium enterprises (MSMEs) — remain central to the discussion. The talks, held under the framework of the India-U.S. Trade Policy Forum (TPF), seek to resolve long-standing issues related to market access, agricultural tariffs, digital trade, and intellectual property.

India and the United States are stepping up efforts to expand their energy trade partnership, underscoring a shared interest in energy diversification, trade balance, and geopolitical alignment. India aims to increase imports of U.S. crude oil, liquefied natural gas (LNG), and other energy products to enhance energy security and reduce dependence on traditional suppliers. The move also seeks to address U.S. concerns over India’s continued purchases of Russian oil.

Indian pharmaceutical major Lupin Ltd. has announced plans to invest USD 250 million in establishing a new manufacturing facility in the United States, marking a major step in its global expansion strategy. The move aims to strengthen Lupin’s presence in the world’s largest pharmaceutical market and enhance its production capabilities in complex generics and specialty products. The facility will cater to both domestic and export markets, reinforcing the company’s commitment to quality manufacturing, innovation, and compliance with global regulatory standards.

India’s economy is forecasted to expand at 6.5% in the fiscal year 2025-26, reflecting steady domestic demand, investment growth, and resilient consumption patterns. However, analysts caution that rising US tariffs and global trade tensions may pose headwinds for India’s export-driven sectors, potentially affecting the country’s trade balance and manufacturing growth. Policymakers are expected to monitor these external developments closely while implementing structural reforms to sustain growth momentum.

The U.S. State Department has released a detailed report assessing Sri Lanka’s investment climate, emphasizing both opportunities and ongoing challenges in the island nation’s economic landscape. The report highlights potential growth sectors, including tourism, infrastructure, energy, and technology, while noting areas of concern such as regulatory uncertainty, political instability, and foreign exchange volatility.

Indian pharmaceutical giant Lupin has secured approval from the United States Food and Drug Administration (USFDA) for its generic Risperidone injection, a widely used treatment for schizophrenia and bipolar disorder. The approval allows Lupin to market the injectable formulation in the U.S., one of the world’s largest pharmaceutical markets. This regulatory milestone strengthens Lupin’s central nervous system (CNS) portfolio, expands its footprint in high-value generics, and demonstrates its capability to meet stringent international compliance standards.

Caplin Point Laboratories has secured approval from the U.S. Food and Drug Administration (USFDA) for its Milrinone Lactate Injection, a critical drug used in treating patients with severe heart failure. The regulatory clearance represents a significant step for the Chennai-based pharmaceutical company as it seeks to expand its footprint in the U.S. generics market.

Natco Pharma has announced the launch of a new generic drug in the United States, strengthening its presence in one of the world’s most lucrative pharmaceutical markets. The move underscores the company’s strategy to enhance global accessibility to affordable medications while diversifying its international portfolio. By introducing this generic alternative, Natco aims to capture market share in a highly competitive landscape dominated by established players.

Facebook’s grip on younger audiences is slipping — and the implications stretch far beyond social media. Data from Pew Research Center, Sprout Social, and Meta’s own reports confirm that teens and young adults are abandoning Facebook for TikTok, Instagram, and Snapchat. Meta is fighting back with creator incentives and product changes, but the cultural shift may be deeper than any algorithm tweak can fix.

Here’s what the latest numbers reveal — and why investors and marketers should pay close attention.

BetMGM, a leading player in the sports betting and online gaming industry, has launched an innovative advertising campaign featuring Hollywood star Jamie Foxx. This marks the company's first significant venture into promoting its online casino operations. The ad titled "Vegas Lights" underscores BetMGM’s commitment to delivering a seamless gaming experience by bridging its digital platform with MGM Resorts' physical casino destinations. Debuting on March 4, 2025, the 30-second commercial creatively spotlights renowned MGM Resorts locations, aligning retail and online gaming experiences.